Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald P Levine

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Antimicrobial Agents|July 3, 2017
Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infectionsKimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 25, 2008
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsMichael Rybak, Ben Lomaestro, John C Rotschafer, et al.
Infectious Diseases and Therapy|September 24, 2018
Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare SettingKimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditisAnthony M Casapao, Thomas P Lodise, Susan L Davis, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2007
Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremiaMark E Rupp, H Preston Holley, Jon Lutz, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2014
Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureusAnthony M Casapao, Susan L Davis, John Paul McRoberts, et al.
Pharmacotherapy|October 31, 2009
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Ben M Lomaestro, John C Rotschafer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2009
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Ben M Lomaestro, John C Rotschafer, et al.
Pharmacotherapy|September 20, 2011
High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective studyRavina Kullar, Susan L Davis, Donald P Levine, et al.
Infectious Diseases and Therapy|February 23, 2018
Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus InfectionsTrang D Trinh, Evan J Zasowski, Kimberly C Claeys, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Antimicrobial Agents|July 3, 2017
Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infectionsKimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 25, 2008
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsMichael Rybak, Ben Lomaestro, John C Rotschafer, et al.
Infectious Diseases and Therapy|September 24, 2018
Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare SettingKimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditisAnthony M Casapao, Thomas P Lodise, Susan L Davis, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2007
Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremiaMark E Rupp, H Preston Holley, Jon Lutz, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2014
Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureusAnthony M Casapao, Susan L Davis, John Paul McRoberts, et al.
Pharmacotherapy|October 31, 2009
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Ben M Lomaestro, John C Rotschafer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2009
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Ben M Lomaestro, John C Rotschafer, et al.
Pharmacotherapy|September 20, 2011
High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective studyRavina Kullar, Susan L Davis, Donald P Levine, et al.
Infectious Diseases and Therapy|February 23, 2018
Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus InfectionsTrang D Trinh, Evan J Zasowski, Kimberly C Claeys, et al.
Pageof 5